“Estimating background rates of Guillain-Barré Syndrome in Ontario in order to respond to safety concerns during pandemic H1N1/09 immunization campaign”
http://www.biomedcentral.com/1471-2458/11/329
Excerpt from conclusions:
“Our analyses do not suggest an increased number of GBS cases due to the vaccine.”